<SEC-DOCUMENT>0000950170-23-067364.txt : 20231201
<SEC-HEADER>0000950170-23-067364.hdr.sgml : 20231201
<ACCEPTANCE-DATETIME>20231201163129
ACCESSION NUMBER:		0000950170-23-067364
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		16
CONFORMED PERIOD OF REPORT:	20231127
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231201
DATE AS OF CHANGE:		20231201

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Orthofix Medical Inc.
		CENTRAL INDEX KEY:			0000884624
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1223

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-19961
		FILM NUMBER:		231459994

	BUSINESS ADDRESS:	
		STREET 1:		3451 PLANO PARKWAY
		CITY:			LEWISVILLE
		STATE:			TX
		ZIP:			75056
		BUSINESS PHONE:		214-937-2000

	MAIL ADDRESS:	
		STREET 1:		3451 PLANO PARKWAY
		CITY:			LEWISVILLE
		STATE:			TX
		ZIP:			75056

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ORTHOFIX INTERNATIONAL N V
		DATE OF NAME CHANGE:	19970708
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ofix-20231127.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="ASCII"?><!-- DFIN New ActiveDisclosure (SM) Inline XBRL Document - http://www.dfinsolutions.com/ --><!-- Creation Date :2023-12-01T14:22:04.9131+00:00 --><!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<html xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:nonNumeric="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:ofix="http://www.orthofix.com/20231127" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2022-02-16">
 <head>
  <title>8-K</title>
  <meta http-equiv="Content-Type" content="text/html" />
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <div style="display:none;"><ix:header><ix:hidden><ix:nonNumeric id="F_5bdb31d8-d687-4107-bee0-4af134e33bbf" name="dei:EntityCentralIndexKey" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305">0000884624</ix:nonNumeric><ix:nonNumeric id="F_b22f4a5a-6020-436c-a772-eb2c606508d3" name="dei:AmendmentFlag" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="ofix-20231127.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="C_a7326e62-6655-42b6-88c1-3e2f178a2305"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000884624</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-27</xbrli:startDate><xbrli:endDate>2023-11-27</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>
  <p style="border-top:2.25pt double #000000;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5.75pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">UNITED STATES<br />SECURITIES AND EXCHANGE COMMISSION<br /></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">WASHINGTON, D.C. 20549</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:10pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">FORM </span><span style="font-size:18pt;font-family:Times New Roman;"><ix:nonNumeric id="F_573a6153-94a6-40c1-bee0-42b0dd8deff5" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:DocumentType"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:18pt;font-family:Times New Roman;min-width:fit-content;">8-K</span></ix:nonNumeric></span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">CURRENT REPORT</span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:6pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Date of Report (Date of earliest event reported): </span><span><ix:nonNumeric id="F_500bf5ea-88da-40f3-81eb-4d3bff8e95d6" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">November 27, 2023</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="margin-left:40%;font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:5pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="font-size:24pt;font-family:Times New Roman;"><ix:nonNumeric id="F_9da5257b-ac78-4a77-b97d-4f3ef7b3e010" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:EntityRegistrantName"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:24pt;font-family:Times New Roman;min-width:fit-content;">ORTHOFIX MEDICAL INC.</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:3pt;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Exact name of Registrant as Specified in Its Charter)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:20%;"></td>
    <td style="width:1%;"></td>
    <td style="width:20%;"></td>
    <td style="width:18%;"></td>
    <td style="width:41%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_87c32789-6ed9-48a7-90f4-7233b53b0b9f" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Delaware</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_2389cfed-281f-4912-94bf-5e17e5e8c31c" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:EntityFileNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">0-19961</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_7a439cfc-b80d-4f08-8aba-b93220c210f4" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:EntityTaxIdentificationNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">98-1340767</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(State or Other Jurisdiction<br />of Incorporation)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Commission File Number)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(IRS Employer<br />Identification No.)</span></p></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_dd627814-695b-4bd9-968c-695a3a976ce1" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:EntityAddressAddressLine1"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">3451 Plano Parkway</span></ix:nonNumeric></span></p></td>
    <td colspan="2" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_10988c90-7d02-4610-988a-4b9bb66b8416" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:EntityAddressCityOrTown"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Lewisville</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">, </span><span><ix:nonNumeric id="F_516957a8-04d1-4e0f-8c09-168756761edc" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Texas</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:bottom;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_f41a4019-de4e-456b-8aa3-a5d4581a58b2" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:EntityAddressPostalZipCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">75056</span></ix:nonNumeric></span></p></td>
   </tr>
   <tr style="height:7pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td colspan="3" style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Address of Principal Executive Offices)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:7.5pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(Zip Code)</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;margin-right:0.02986111111111111in;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Registrant&#x2019;s Telephone Number, Including Area Code:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_313b9ace-90c8-4934-8419-b5d1c7b1617d" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:CityAreaCode"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">(214)</span></ix:nonNumeric></span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span><span><ix:nonNumeric id="F_81ae6a4a-b586-44ce-8bbe-d97034d20c96" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:LocalPhoneNumber"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">937-2000</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:100%;"></td>
   </tr>
   <tr style="white-space:pre-wrap;word-break:break-word;text-align:left;">
    <td style="padding-top:0.125in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:7.5pt;font-family:Times New Roman;min-width:fit-content;">(Former Name or Former Address, if Changed Since Last Report)</span></p>
  <p style="margin-left:40%;font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:0;border-bottom:0.75pt solid #000000;margin-right:40%;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:9.35pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:9pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_5bd89842-4aa4-4eb4-ac74-8adde6fa0a8a" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_7f9624c9-d0e5-4b67-88b9-127e832c11ba" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_b805c53a-d286-4868-a855-732635845c3e" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></div>
  <div style="text-indent:-24.5pt;padding-left:24.5pt;margin-top:6pt;margin-bottom:0;text-align:left;"><span style="margin-right:1em;margin-right:1em;"><span style="font-size:10pt;font-family:Times New Roman;"><ix:nonNumeric id="F_d408c16d-66d5-4a35-8e29-a0595f681b1a" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></div>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:9pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Securities registered pursuant to Section 12(b) of the Act:</span></p>
  <table style="border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:38%;"></td>
    <td style="width:1%;"></td>
    <td style="width:15%;"></td>
    <td style="width:1%;"></td>
    <td style="width:45%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br />Title of each class</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;">Trading<br />Symbol(s)</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;border-bottom:0.25pt solid;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;min-width:fit-content;"><br />Name of each exchange on which registered</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_01a8bd1d-a426-477d-8cf7-6b77e14ab9a4" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:Security12bTitle"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Common stock, $0.10 par value per share</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_f11c382a-2945-4818-a89a-35132dd0ff3d" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:TradingSymbol"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">OFIX</span></ix:nonNumeric></span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="padding-top:0.01in;vertical-align:top;text-align:left;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><span><ix:nonNumeric id="F_56e99c76-a3b3-464a-86f5-dc7a5a1981bd" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Nasdaq Global Select Market</span></ix:nonNumeric></span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;&#x202f;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;&#x202f;240.12b-2 of this chapter).</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Emerging growth company </span><span style="font-size:10pt;"><ix:nonNumeric id="F_96079a35-816b-49ae-b6c6-7bfc34e5c435" contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox"><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></ix:nonNumeric></span></p>
  <p style="font-size:10pt;margin-top:9pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. </span><span style="font-size:10pt;font-family:Times New Roman;">&#9744;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;border-bottom:2.25pt double #000000;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="text-indent:-11.441%;padding-left:10.267%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 5.02	Departure of Directors of Principal Officers; Election of Directors; Appointment of Principal Officers.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Announcement of Massimo Calafiore as President and Chief Executive Officer</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 28, 2023, Orthofix Medical Inc. (&#x201c;Orthofix&#x201d; or the &#x201c;Company&#x201d;) announced that Massimo Calafiore and the Company have agreed that Mr. Calafiore will become the Company&#x2019;s President and Chief Executive Officer. Mr. Calafiore currently serves as Chief Executive Officer of LimaCorporate S.p.A., a global orthopedics company, and his appointment as Orthofix&#x2019;s President and Chief Executive Officer is expected to be effective in early 2024, following the completion of LimaCorporate&#x2019;s previously announced acquisition by Enovis Corporation. The terms of Mr. Calafiore&#x2019;s appointment are further set forth in a letter agreement between Mr. Calafiore and the Company (the &#x201c;Offer Letter Agreement&#x201d;), entered into on November 27, 2023. The determination to offer Orthofix&#x2019;s President and Chief Executive Officer position to Mr. Calafiore, and the terms of the Offer Letter Agreement, were each unanimously approved by the Company&#x2019;s Board of Directors (the &#x201c;Board&#x201d;). Catherine M. Burzik, who currently serves as Interim Chief Executive Officer, will continue in that role until Mr. Calafiore begins employment.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Mr. Calafiore, 52, has served since September 2022 as the President and Chief Executive Officer of LimaCorporate S.p.A., a global orthopedic company focused on restoring motion through digital innovation and customized hardware, which is currently in the process of being acquired by Enovis Corporation. Previously, Mr. Calafiore served from September 2021 through August 2022 as Executive Vice President and Chief Commercial Officer of NuVasive, Inc., where he oversaw product marketing, commercial and commercial enablement functions, as well as NuVasive&#x2019;s specialized orthopedics and clinical services. From October 2020 through August 2021, he served as NuVasive&#x2019;s Executive Vice President, Global Business Units, where he was responsible for NuVasive&#x2019;s product and services organization, including Spine, NuVasive Specialized Orthopedics (NSO) and NuVasive Clinical Services, and commercial enablement such as clinical professional development and global marketing. From 2017 until October 2020 he held various other leadership roles at NuVasive with increasing levels of responsibility, serving as Senior Vice President, Spine Business Unit, from January 2020 to October 2020, Senior Vice President, Global Implant Systems and General Manager of NSO, from February 2019 to December 2019, and Senior Vice President, General Manager of NSO from August 2017 to February 2019. Before his executive service at NuVasive, he spent more than 15 years supporting and leading the U.S. business for Waldemar Link, a leader in the orthopedics and medical device industry.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Under the terms of the Offer Letter Agreement, Mr. Calafiore will receive an annual base salary of $825,000 per year, and a target bonus opportunity under the Company&#x2019;s annual incentive program of 110% of such base salary. As an inducement to entering into employment with the Company, he will receive (i) sign-on equity incentive awards with a grant date fair value of $3,500,000, and (ii) 2024 annual equity incentive awards with a grant date fair value of $4,000,000 (collectively, the &#x201c;Inducement Awards&#x201d;). The Inducement Awards, which will be granted effective as of Mr. Calafiore&#x2019;s first date of employment with the Company pursuant to NASDAQ Marketplace Rule 5635(c)(4), will be allocated (i) 50% as performance-based vesting restricted stock units determined at the end of a 3-year performance period based on the Company&#x2019;s total stockholder return relative to an industry peer group index during such period, (ii) 25% as stock options that vest upon achievement of both service- and performance-based criteria, whichever is the later of (a) the date certain service-based conditions are met (which will be met over three years) and (b) the date that the average closing price of the Company&#x2019;s common stock over a one-month calendar period has been equal to or great than 150% of the closing price of the Company&#x2019;s common stock on the grant date, and (iii) 25% as time-based restricted stock units vesting in equal tranches over three years. Mr. Calafiore will be provided an executive level after-tax relocation payment of $225,000 to support establishing residency in the San Diego, CA area.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">The Compensation and Talent Development Committee of the Board, with the assistance of its independent compensation consultant, designed the sign-on package to be aligned with industry benchmarks, the Company&#x2019;s pay-for-performance philosophy, and shareholder interests. The sign-on equity-based awards are being delivered as 75 percent at-risk performance-based component that delivers value only if the Company achieves sustained absolute or relative shareholder value creation goals and 25% as only a time-based element. The Committee will be setting performance metrics for its cash-based annual incentive program in the first quarter of 2024, consistent with its regular practice and corporate priorities established by the Board of Directors for the fiscal year.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with his employment, Mr. Calafiore will be provided the opportunity to enter into a CEO change in control and severance agreement and indemnification agreement. The foregoing descriptions do not purport to be complete and are qualified in their entirety by reference to the full text of the Offer Letter Agreement, which is filed herewith as Exhibit 10.1 and incorporated herein by reference.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Board Service of Catherine M. Burzik</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:6pt;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">In connection with the finalization of these matters, Ms. Burzik has informed the Board that she has elected not to stand for re-election to the Board at the Company&#x2019;s annual meeting of shareholders in 2024 (the &#x201c;2024 Annual Meeting&#x201d;). Ms. Burzik&#x2019;s decision not to stand for re-election to the Board is not due to any disagreement with the Company regarding its operations, policies or practices. Ms. Burzik will continue in her role of Chair of the Board until her Board service expires at the 2024 Annual Meeting.</span><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:6pt;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 7.01 	Regulation FD Disclosures.</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">On November 28, 2023, the Company issued a press release concerning the matters disclosed in Item 5.02 above. The information furnished in this Item 7.01 will not be treated as &#x201c;filed&#x201d; for the purposes of Section 18 of the Exchange Act, or otherwise subject to the liabilities of that section. This information will not be deemed incorporated by reference into any filing under the Securities Act, or into another filing under the Exchange Act, unless that filing expressly incorporates by reference this Item 7.01 of this report.</span></p>
  <hr style="page-break-after:always;" />
  <p style="font-size:10pt;margin-top:12pt;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Item 9.01.	Financial Statements and Exhibits.</span></p>
  <p style="font-size:10pt;margin-top:6pt;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="color:#252525;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">(d)	Exhibits</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><span style="white-space:pre-wrap;font-size:6pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:100.0%;border-collapse:separate;margin-right:auto;">
   <tr style="visibility:collapse;">
    <td style="width:5%;"></td>
    <td style="width:95%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#252525;white-space:pre-wrap;min-width:fit-content;">10.1</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ofix-ex10_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Letter agreement, entered into on November 27, 2023, between Orthofix Medical Inc. and Massimo Calafiore.</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#252525;white-space:pre-wrap;min-width:fit-content;">99.1</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><a href="ofix-ex99_1.htm"><span style="color:#0000ff;white-space:pre-wrap;text-decoration:underline;min-width:fit-content;">Press release, dated November 28, 2023.</span></a></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">104</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:10pt;text-align:center;"><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">SIGNATURES</span><span style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. 	</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:43.0%;border-collapse:separate;">
   <tr style="visibility:collapse;">
    <td style="width:10.46%;"></td>
    <td style="width:10.46%;"></td>
    <td style="width:78.08%;"></td>
    <td style="width:1%;"></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td colspan="3" style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Orthofix Medical Inc.</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">By:</span><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;"> </span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;border-bottom:0.5pt solid;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">/s/ Catherine M. Burzik</span></p></td>
    <td style="vertical-align:top;border-bottom:0.5pt solid #ffffff03;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
   <tr style="height:10pt;white-space:pre-wrap;word-break:break-word;">
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Catherine M. Burzik</span></p><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;min-width:fit-content;">Interim Chief Executive Officer<br />&#160;and Chair of the Board of Directors</span></p></td>
    <td style="vertical-align:top;"><p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;min-width:fit-content;">&#160;</span></p></td>
   </tr>
  </table>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Date: December 1, 2023</span></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><span style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</span></p>
  <hr style="page-break-after:always;" />
 </body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ofix-ex10_1.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html>
 <head>
  <title>EX-10.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 10.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><img src="img49266718_0.jpg" alt="img49266718_0.jpg" style="width:624px;height:85px;">&#160;</p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">November 27, 2023</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Massimo Calafiore</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Via L. Castelvetro 18</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Modena, Italy 41124</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Dear Massimo:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">It gives me great pleasure to present this offer of employment with Orthofix Medical, Inc. (with its subsidiaries and affiliates, &#x201c;Orthofix&#x201d;).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Position:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  The position we are offering you is that of President and Chief Executive Officer. We also expect that the Orthofix Board of Directors will appoint you as one of its members.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Start Date:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  Your anticipated starting date is expected to be effective mid- to late-January 2024, promptly following the completion of LimaCorporate&#x2019;s previously announced acquisition by Enovis Corporation (NYSE: ENOV).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Base Salary:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  Your base salary will be $825,000 per year (the &#x201c;Base Salary&#x201d;), less applicable deductions and tax withholdings.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Annual Bonus:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  Subject to Orthofix policies and satisfaction of applicable performance criteria, you will be eligible to participate in the annual bonus program, with a target bonus opportunity of 110% of your Base Salary.  Your 2024 annual bonus will not be pro-rated based on your start date.  The annual bonus, if payable, will be paid at the same time that such bonuses are paid to other executives, and will be designed to either be exempt from or comply with Internal Revenue Code Section 409A, as determined by the Compensation and Talent Development Committee of Orthofix&#x2019;s Board of Directors (the &#x201c;C&amp;TD Committee&#x201d;) upon establishment each year.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Sign-On Equity Award ($3,500,000):</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  As an inducement to and incentive for accepting this position, you will be receive a grant, effective as of your start date, of (i) performance-based restricted stock units (&#x201c;P-RSUs&#x201d;), valued at $1,750,000 (based on the closing price of Orthofix common stock on the grant date, subject to rounding to the nearest whole unit), (ii) Stock Options to purchase shares of Orthofix common stock, valued at $875,000 (based on the Black-Scholes value of Orthofix common stock on the grant date, subject to rounding to the nearest whole option share), and (iii) restricted stock units (&#x201c;RSUs&#x201d;) with respect to shares of Orthofix common stock, valued at $875,000 (based on the closing price of Orthofix common stock on the grant date, subject to rounding to the nearest whole unit). All such awards will be subject to continued employment through applicable vesting dates (subject to any applicable acceleration rights).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> MACROBUTTON DocID \\4161-1083-5021  v2</font><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">P-RSUs vesting determined at the end of the 3-year performance period based on Orthofix total shareholder return relative to an industry peer group index, which vesting may be anywhere from 0% to 200% of the target P-RSU amount based on the achievement of the performance goals.  If during the term of the Stock Options the average closing price of the Company&#x2019;s common stock over a one-month calendar period has been equal to or greater than 150% of the closing price of the Company&#x2019;s common stock on the grant date (the &#x201c;Sign-On Option Exercise Condition&#x201d;), the Stock Options will vest upon the later of (i) the date on which the Sign-On Option Exercise Condition is achieved and (ii) the date on which you meet the applicable service-based conditions.  The applicable service-based conditions will be met with respect to 1/3 of the Stock Options on the one-year anniversary of the Stock Options&#x2019; grant date and with respect to 1/12 of the Stock Options as of the end of each 3-month period during the two years following such one-year anniversary of the grant date.  RSUs will vest in annual 33-1/3% installments, with the first tranche vesting on the one-year anniversary of the RSUs&#x2019; grant date and the second and third tranches vesting on the two and three year anniversaries of the grant date, respectively.  Upon any future Change in Control (as defined under the Change in Control and Severance Agreement), (i) the performance goals for the P-RSUs will be deemed achieved at the greater of 100% of target or actual achievement through the Change in Control closing date and (ii) the Sign-On Option Exercise Condition will be deemed achieved. The sign-on equity awards will be subject to the terms and conditions of applicable award agreements.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Annual 2024 Equity Incentive Award ($4,000,000):</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> As a further inducement to and incentive for accepting this position, you will receive a grant, effective as of your start date, of (i) P-RSUs, valued at $2,000,000 (based on the closing price of Orthofix common stock on the grant date, subject to rounding to the nearest whole unit), (ii) Stock Options to purchase shares of Orthofix common stock, valued at $1,000,000 (based on the Black-Scholes value of Orthofix common stock on the grant date, subject to rounding to the nearest whole option share), and (ii) RSUs with respect to shares of Orthofix common stock, valued at $1,000,000 (based on the closing price of Orthofix common stock on the grant date, subject to rounding to the nearest whole unit). All such awards will be subject to continued employment through applicable vesting dates (subject to any applicable acceleration rights).</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">P-RSUs vesting determined at the end of the 3-year performance period based on Orthofix total shareholder return relative to an industry peer group index, which vesting may be anywhere from 0% to 200% of the target P-RSU amount based on the achievement of the performance goals.  If during the term of the Stock Options the average closing price of the Company&#x2019;s common stock over a one-month calendar period has been equal to or greater than 150% of the closing price of the Company&#x2019;s common stock on the grant date (the &#x201c;2024 Option Exercise Condition&#x201d;), the Stock Options will vest upon the later of (i) the date on which the Sign-On Option Exercise Condition is achieved and (ii) the date on which you meet the applicable service-based conditions.  The applicable service-based conditions will be met with respect to 1/3 of the Stock Options on the one-year anniversary of the Stock Options&#x2019; grant date and with respect to 1/12 of the Stock Options as of the end of each 3-month period during the two years following such one-year anniversary of the grant date. RSUs will vest in annual 33-1/3% installments, with the first tranche vesting on the one-year anniversary of the RSUs&#x2019; grant date and the second and third tranches vesting on the two and three year anniversaries of the grant date, respectively. Upon any future Change in Control (as defined under the Change in Control and Severance Agreement), (i) the performance goals for the</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> MACROBUTTON DocID \\4161-1083-5021  v2</font><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">P-RSUs will be deemed achieved at the greater of 100% of target or actual achievement through the Change in Control closing date and (ii) the 2024 Option Exercise Condition will be deemed achieved. These sign-on annual 2024 equity incentive awards will be subject to the terms and conditions of applicable award agreements. For the avoidance of doubt, the 2024 Option Exercise Condition is intended as a one-time performance incentive and will not necessarily apply to future stock awards (i.e., for 2025 and future years), the terms and conditions of which will be determined by the C&amp;TD Committee.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Benefits:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  Orthofix will offer you medical, dental, and vision insurance, effective the first of the month after your first 30 days of employment.  You will also be eligible to participate in the Orthofix 401(k) retirement plan as of the first of the month after your first 30 days of employment.  This plan currently provides an employer match of 100% for the first 2% contribution and 50% for the next 4% contribution.  A more detailed explanation of these benefits and other benefits will be provided to you under separate cover.  Orthofix defers to the provisions of its employee benefits plans, which plans shall govern to the extent of any conflict and which plans may be changed unilaterally by Orthofix.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Relocation Assistance:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  Your position will be based in Orthofix&#x2019;s Carlsbad, CA offices and as such, Orthofix will provide you with a relocation payment, to be paid to you on May 1, 2024, in an amount such that the estimated after-tax portion (calculated to assume that you are subject to U.S. federal and California state income tax, but not subject to income tax in any other jurisdiction) of such amount will be equal to $225,000, such payment to be used  for expenses to support establishing residency in the San Diego, CA area on or before August 15, 2024.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Third-Party Confidentiality/Non-Compete Obligations:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  Orthofix recognizes that, while you were employed with your prior employers, you may have been exposed to confidential, proprietary, and/or trade secret information (&#x201c;Third-Party Confidential Information&#x201d;).  Moreover, Orthofix recognizes that you have a legal duty and may have a contractual duty not to use or disclose Third-Party Confidential Information outside of your employment with your former employers.   Orthofix also recognizes that you may owe your former employers a contractual duty not to solicit certain customers (&#x201c;Restricted Customers&#x201d;).  Orthofix has no intention of obtaining any Third-Party Confidential Information in any form.  In fact, Orthofix&#x2019;s expectation is that you will abide by, and comply fully with, the terms of any agreements you may have with respect to such information.  By signing below, you represent and warrant that you have complied, and will comply, with any such obligations, including, but not limited to, all confidentiality, non-solicitation, non-competition, and post-employment disclosure obligations.  You further represent and warrant that you have not misappropriated any Third-Party Confidential Information and, to the extent you may have access to such information, you will not disclose or use it for any purpose contrary to the terms of any agreements you may have with respect to such information, or to benefit Orthofix in any way.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Orthofix also wishes to ensure that you are not placed in a position which might require you to solicit Restricted Customers or cause the disclosure or use of Third-Party Confidential Information, either intentionally or inadvertently.  If you are ever involved in any job situation which could require you to solicit Restricted Customers or cause you to use or disclose any Third-Party Confidential Information, you agree to immediately notify Orthofix&#x2019;s Chief Legal Officer</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> MACROBUTTON DocID \\4161-1083-5021  v2</font><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">and advise Orthofix&#x2019;s Chief Legal Officer of your concerns.  In the event it is determined that a risk of improper solicitation, disclosure, or use does exist, Orthofix will take appropriate measures.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Employment-At-Will</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  You understand and acknowledge that, if you become employed by Orthofix, you will be an &#x201c;at-will&#x201d; employee at all times during your employment.  As an at-will employee, both Orthofix and you will have the right to terminate your employment at any time, with or without cause, and with or without notice.  At-will employment also means that your job duties, title, compensation, and benefits, as well as the company personnel policies and other procedures, may be changed or terminated at the sole discretion of Orthofix at any time.  Please note that, while this offer letter summarizes your anticipated terms and conditions of employment with Orthofix, they may change, and it is </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">not</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;"> an employment contract.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Other Agreements:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  Under separate cover, you will receive a Change in Control and Severance Agreement, a Dispute Resolution Agreement, a Confidentiality and Invention Assignment Agreement, and an Indemnification Agreement (the &#x201c;Other Agreements&#x201d;), which will become effective as of your first day of employment. Additionally, OFIX agrees to promptly reimburse you for (a) tax planning/tax return preparation expenses incurred by you for your Italy, US, and state/local tax returns for each calendar year during which you are employed by the Company and (b) the cost of legal fees up to $25,000 to review these employment agreements.  Any expense reimbursements or in kind benefits under this offer letter that constitute deferred compensation within the meaning of Section 409A of the Internal Revenue Code shall be made or provided in accordance with the requirements of Section 409A, including, without limitation, that: (i) the expenses eligible for reimbursement or the amount of in-kind benefits provided in one taxable year shall not affect the expenses eligible for reimbursement or the amount of in-kind benefits provided in any other taxable year; (ii) the reimbursement of an eligible expense shall be made no later than the end of the year after the year in which such expense was incurred; and (iii) the right to reimbursement or in-kind benefits shall not be subject to liquidation or exchange for another benefit.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;text-decoration:underline;font-size:12pt;font-family:Times New Roman;font-style:italic;min-width:fit-content;">Acceptance:</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  Your signature at the end of this offer letter constitutes an acceptance of this offer and confirms that no promises, representations, or agreements that are inconsistent with any of the terms of this offer letter have been made to or with you by anyone at Orthofix.  Upon acceptance of this Offer Letter the offer and the terms set forth herein are binding and irrevocable by Orthofix until and following the effectiveness of the Change of Control and Severance Agreement.</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Massimo, we look forward to working with you. Your experience, background and leadership will be a significant asset to Orthofix.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Sincerely,</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/s/ Catherine M. Burzik					</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Catherine M. Burzik</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Chair of the Board and Interim President and Chief Executive Officer</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">ACKNOWLEDGED, ACCEPTED, AND AGREED:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> MACROBUTTON DocID \\4161-1083-5021  v2</font><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;text-decoration:underline;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">/s/ Massimo Calafiore	</font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">	Date: November 27, 2023</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:Times New Roman;min-width:fit-content;">Massimo Calafiore</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> MACROBUTTON DocID \\4161-1083-5021  v2</font><font style="color:#000000;white-space:pre-wrap;font-size:6pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-size:12pt;font-family:'Calibri',sans-serif;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>ofix-ex99_1.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html>
 <head>
  <title>EX-99.1</title>
 </head>
 <body style="margin: auto!important;padding: 8px;">
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:right;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;"> </font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">Exhibit 99.1</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><img src="img236010591_0.jpg" alt="img236010591_0.jpg" style="width:198px;height:31px;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">                                                                                                          </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Arial;min-width:fit-content;">Orthofix Medical Inc.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Arial;min-width:fit-content;">3451 Plano Parkway</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Arial;min-width:fit-content;">Lewisville, TX 75056 USA</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Arial;min-width:fit-content;">Tel   214 937 2000</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:7.5pt;font-family:Arial;min-width:fit-content;">Orthofix.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#0070c0;white-space:pre-wrap;font-size:20pt;font-family:Arial;min-width:fit-content;">News Release</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Orthofix Names Massimo Calafiore as President and Chief Executive Officer</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Value-Building Medical Device Executive with 20-Year Record of Driving Market-Leading Growth</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Across Orthopedics and Spine Businesses</font></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;">Global Leader with Extensive M&amp;A Integration Expertise and Commercial and Operating Experience Across Key Orthofix Geographies</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;font-style:italic;min-width:fit-content;"> </font></p>
  <p style="text-indent:4.173%;font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:center;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">LEWISVILLE, TEXAS &#x2014; November 28, 2023 &#x2014; Orthofix Medical Inc. (NASDAQ:OFIX), a leading global spine and orthopedics company, announced today that Massimo Calafiore has been named incoming President and Chief Executive Officer. Mr. Calafiore is currently Chief Executive Officer of LimaCorporate S.p.A., a global orthopedics company, and his appointment to Orthofix is expected to be effective in early 2024, following the completion of LimaCorporate&#x2019;s previously announced acquisition by Enovis Corporation (NYSE: ENOV). At that time, Mr. Calafiore is also expected to join Orthofix&#x2019;s Board of Directors.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;The Board of Directors unanimously determined that Massimo is the right choice to lead Orthofix given his exceptional track record of delivering value creation and his extensive knowledge of the medical device industry, specifically within orthopedics and spine,&#x201d; said Catherine Burzik, Chair of the Board of Directors and Interim CEO of Orthofix. &#x201c;Throughout his career, Massimo has demonstrated his ability to unlock value opportunities for multi-segmented, global businesses. He has successfully driven sales and commercial operations to achieve both industry leading profitability and growth. Importantly, he has proven experience integrating companies and building high performing teams.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:justify;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#x201c;Having worked in orthopedics and spine throughout my entire career, I know Orthofix well and have long admired the Company and its talented team,&#x201d; said Mr. Calafiore. &#x201c;I was attracted to Orthofix given the many growth opportunities created by its unique, broad-based portfolio and high-quality distributor relationships. I am also impressed with the innovative solutions Orthofix has developed to meet the needs of surgeons and the patients it serves. At this pivotal time for the Company, I look forward to working with the Board and leadership team to capture Orthofix&#x2019;s significant profitable growth potential and drive enhanced shareholder value.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Mr. Calafiore is an accomplished global business leader with an excellent track record across multiple companies in the orthopedics and spine industry. Throughout his career he has demonstrated a commitment to operating excellence, ethical integrity and DE&amp;I values.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">He has been CEO of LimaCorporate since September 2022. During this time, Mr. Calafiore strengthened and reshaped the company&#x2019;s strategy and culture priorities, with an emphasis on fostering, mentoring and retaining talent. His leadership resulted in consecutive quarter-over-quarter above-market growth; best-in-class EBITDA margins; and substantial improvement in employee engagement and retention. On September 25, 2023, LimaCorporate announced its sale to Enovis Corporation for &#x20ac;800 million.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Prior to LimaCorporate, he served as Executive Vice President and Chief Commercial Officer of NuVasive, Inc. and delivered consecutive quarter-over-quarter above-market growth in all core geographies, including the U.S., APAC, EMEA and Japan, and successfully launched multiple products globally, which became foundational to NuVasive&#x2019;s portfolio offering.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">At the beginning of his tenure at NuVasive, Mr. Calafiore served as President of NuVasive Specialized Orthopedics (formerly Ellipse Technologies). In this role, he helped to further integrate the Ellipse business with NuVasive, achieving multiple quarters of accelerated revenue growth with above-market operation margin expansion. NuVasive Specialized Orthopedics is today an important player in complex trauma and limb reconstruction for adults and children, a market segment where Orthofix is also a recognized leader.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Earlier in his career, Mr. Calafiore worked for Waldemar Link GmbH &amp; Co. KG and served in various leadership roles across multiple business segments, including orthopedics, lower extremities and spine. He oversaw the sales of the STAR Ankle to Small Bone Innovations and the PCM Cervical disc to NuVasive.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">He holds an M.Sc. in Mechanical Engineering from the University of Catania and an MBA from New York University.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">The Company also announced that Ms. Burzik has notified the Board that she has elected to not stand for reelection to the Board at the 2024 Annual Meeting.</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Ms. Burzik said, &#x201c;It is an honor to serve as Interim CEO and work closely with Orthofix&#x2019;s amazing employees. The organization is on solid footing, and I will be delighted to turn the Company over to Massimo&#x2019;s very capable hands and plan to work closely with him in the following months to ensure a seamless transition.&#x201d;</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">  </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">The Board retained Heidrick &amp; Struggles, a leading global executive search firm, to assist in its search process.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">About Orthofix</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Orthofix is a leading global spine and orthopedics company with a comprehensive portfolio of biologics, innovative spinal hardware, bone growth therapies, specialized orthopedic solutions, and a leading surgical navigation system. Its products are distributed in approximately 68 countries worldwide.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">The Company is headquartered in Lewisville, Texas and has primary offices in Carlsbad, CA, with a focus on spine and biologics product innovation and surgeon education, and Verona, Italy, with an emphasis on product innovation, production, and medical education for orthopedics. The combined Company&#x2019;s global R&amp;D, commercial and manufacturing footprint also includes facilities and offices in Irvine, CA, Toronto, Canada, Sunnyvale, CA, Wayne, PA, Olive Branch, MS, Maidenhead, UK, Munich, Germany, Paris, France and Sao Paulo, Brazil.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Forward-Looking Statements</font><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">This news release may include forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended. In some cases, you can identify forward-looking statements by terminology such as &#x201c;may,&#x201d; &#x201c;will,&#x201d; &#x201c;should,&#x201d; &#x201c;expects,&#x201d; &#x201c;plans,&#x201d; &#x201c;anticipates,&#x201d; &#x201c;believes,&#x201d; &#x201c;estimates,&#x201d; &#x201c;projects,&#x201d; &#x201c;intends,&#x201d; &#x201c;predicts,&#x201d; &#x201c;potential,&#x201d; &#x201c;continue&#x201d; or other comparable terminology. Orthofix cautions you that statements included in this news release that are not a description of historical facts are forward-looking statements that are based on the Company&#x2019;s current expectations and assumptions. Each forward-looking statement contained in this news release is subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statement. Applicable risks and uncertainties include, among others: the ability of newly launched products to perform as designed and intended and to meet the needs of surgeons and patients, including as a result of the lack of robust clinical validation; and the risks identified under the heading &#x201c;Risk Factors&#x201d; in Orthofix Medical Inc.&#x2019;s Annual Report on Form 10-K for the fiscal year ended December 31, 2022, which was filed with the Securities and Exchange Commission (SEC) on March 6, 2023. The Company&#x2019;s public filings with the Securities and Exchange</font><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;"> </font></p>
  <hr style="page-break-after:always;">
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Commission are available at www.sec.gov. You are cautioned not to place undue reliance on forward-looking statements, which speak only as of the date when made. Orthofix does not intend to revise or update any forward-looking statement set forth in this news release to reflect events or circumstances arising after the date hereof, except as may be required by law.</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Contacts:</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Media Relations</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Denise Landry</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">DeniseLandry@orthofix.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">214.937.2529</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">&#160;</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-weight:bold;font-size:10pt;font-family:Arial;min-width:fit-content;">Investor Relations</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">Louisa Smith, Gilmartin Group</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="color:#000000;white-space:pre-wrap;font-size:10pt;font-family:Arial;min-width:fit-content;">IR@orthofix.com</font></p>
  <p style="font-size:10pt;margin-top:0;font-family:Times New Roman;margin-bottom:0;text-align:left;"><font style="white-space:pre-wrap;font-size:10pt;font-family:Times New Roman;min-width:fit-content;">&#160;</font></p>
  <hr style="page-break-after:always;">
 </body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>img49266718_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img49266718_0.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" &("R # 2(  A$! Q$!_\0
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BC%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M[]>U ',T5^I^@_\ !%.TUG0]/OS\2IHS=6Z3%/L"G;N4''WO>KW_  Y!L_\
MHIT__@O7_P"*H _**BOU=_X<@V?_ $4Z?_P7K_\ %4?\.0;/_HIT_P#X+U_^
M*H _**BOU<_X<@V?_13IO_!>O_Q5+_PY!L_^BFS_ /@O'_Q5 'Y145^KR_\
M!$&RW#=\3KC'?&GK_P#%5\O?LH_L'0_M*?$KXA>%I?%4FBKX5N);<7"VXD,^
MR8QYQGCIF@#Y#QW[4E?J[_PY!L_^BG3_ /@O7_XJO@G]KK]GR/\ 9A^-FI>
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M'B<DJJG7UC+:2V?_  2"BBBO:/G HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ '6M3PYX?O?%6
ML0:;I\?F7,Q^4$X''4UEU['^S+8K<>*M1N"!NM[8,I],G%>IE>$6.QM+#2>D
MGKZ;L\O-,8\!@JN)CO%:>NR-[PQ^S/%'MEUZ_P#,/>WMNG_?5>L>'_!&A^%H
MU73=.A@91CSBN9#]36Y17[S@LGP. M["FK]WJ_O9^ 8W.<=F#_?U6UV6B^Y#
ME8JP/ISBOBGQ]<M=^--:E?JUU)U],]*^U5&3CUXKXG\=PM;^,M:C?[RW<@/_
M 'T:^0XVO]7H]N9_D?9<#6^L5N_*OS,.OHGX!_$Y]4B'AS4Y<W$2_P"BRL>7
M4=5/N*^= <5<TG4[C1=2MKZU<QSP.'1AZBOSO*<RJ97BHUX;;-=U_6Q^CYOE
ME/-<+*A/?>+[/^MS[IZ45E>%=>B\4>';'5(B,7$09AZ-WS^-:M?T13G&K!5(
M.Z:NC^<*E.5*;IS5FG9AZ#/TKA_C)X47Q5X'NPJ!KNS'GPMZ8^]^E=Q220K<
MQO _*2*4;Z'BL<5AX8NA.A/:2L;83$3PE>&(AO%IGP91[]JUO%FFG2?$VIV9
M7:(KAPH'IDX_2LI%,C*HY+' K^9ZD'3FX2W3L?T_3FJD(SCLU<^W?^";?[#L
M/[2'B6?Q;XO@<^!-'E">3DJ;Z?J$!_NC'S?7%?MQH/A_3?"ND6NE:/8P:;IM
MJ@CAM;9 D<:CH !7C?[$/PYM?A?^R]X!TFWB6*6;3X[VYVCK-*H9S^9KW&:1
M8(9)'.$12S'V R:S-#SOXX?M!>!_V=_";Z_XUUF+3K?!$%NOS3W+#^&-.Y_2
MOS]^('_!;2UM;YXO!GP^-]:=KC5KHQ-_WRH/\Z^'OVV_V@-2_:$^/OB/5YK]
MKC0[.X>TTJ $^7% AP,#U)R2:\"H _3?3?\ @MWXDCN!]O\ AGILL!(W>3J$
MBL!W(RO-?8?[-?\ P4?^%G[16IPZ''=2^&?$LF%CT_5,*L[>D3YP?H<5^ M3
MV-]<:;>07=I,]M=02++%-&Q5D=3D$'L010!_5 :^%?\ @H=^P+H/QH\&ZGXW
M\'Z;#IOCW38FN91;J$748U&65P/X\<AO;%>U_L*_'"Y^/O[-WACQ'J3[]9BC
M-E?-G):2([=Y]V !_$U[](BR(R.H96&""."/2@#^62RTNZU#5(-.AA9KV:98
M$AP=Q<G &/7-?OE^PS^Q/X;_ &9_ &GZC>Z?#?>/K^%9;_4ID#/ 6&3#&?X5
M'?'4U\#6GP%L/#__  5@LO#"P(=)_MG^US;N/E\MU:0*/Q(Q7[1T )(ZQQL[
ML%51DLW 'O7RK\:O^"EGP4^"NJ7&E7&M3>)-6MW,<UIHB";RW'\+,2 /UKD/
M^"JWQWUKX5_ ^V\.>&6NH=;\42M;FXM8V9DMD \T @<$[@,U^(;:#J\C,S:;
M>LS')9H')/Z4 ?L?_P /HOA/_P!"UXB_[]Q__%5U_P ./^"MGP2\>:Y;Z7?/
MJOA>29@JW.IP*+?).!EU8XZ^E?B!_P (]JO_ $#+S_P'?_"N\^&/[-OQ)^,&
ML6>G>&/".I7KW,@03M R0Q@G!9F(X4=S[4 ?TJV=Y!J%I!=6TJSV\R+)'*AR
MKJ1D,/8BOD?_ (*1?L[Z1\4?@O=^,;?3H_\ A+O";)J-I=(NUY8T8&2)B.2N
MW) ]0*^E?A;X6N?!'PW\+^'[R43W>F:;!:S2+R&=(PK8]L@UR/[57BRQ\$_L
M[>/]6U&18K:/2IHR7. 6==BC\V% 'Q'X?_X+-^"M'T'3;%_!FJ,]K;1PLRR+
M@E5 R/RK0_X?6>!_^A+U;_OXM?CW10!^^G[)O_!0;P]^U=XXO_#>D>'KW2IK
M2U-TTMPP*D @8XKZSK\8O^"+_P#R7SQ)_P!@AO\ T(5^SU 'R_\ M=?MTZ%^
MR1J^B6&L:%>:NVJ1-*C6Q "A3CG-?/?_  ^L\$?]"5JW_?Q:\S_X+:?\CAX
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M\S7ZZ_L3_L/^%_V6_!=K=7%K#JGCJ\C62^U69 6A8CF*+^ZHZ<=2*^5/V?\
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MNO\ AO\ %#7OA;K0U'0[KRRV!-;OS'*OHPKYG/<H_M6BN1VG';]4?9\,Y_\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M-QQT ZD]A0!^RW_!'6VNX?V9[^2=B8)=5D, )Z #!_6OO"O)OV6?@?!^SO\
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M%8[J>']M#Q&L<TB+_9UAPKD#_4+0!^U/_"Z/ ?\ T-^C?^!B?XT?\+H\!_\
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M@+0H_#/@G0],C78+>TC! [,5!;]<U^?7P?T/_A./C=I<,8W(^H-=G'=58O\
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M=6=?$S<I/N%%%%=)Q!1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%%  *V_!^NMX;\3:?J*G AE4M_
MNDX/Z5B4JUI3J2I3C4ANG=&=2G&M"5.>S5OO/O"VNH[ZVAN82&BF4.I'H1FI
M*\A_9]\>C6M%;0KN7_3;/F'=U>/_ .M7KU?TCE^-IYAAH8BGU6OD^J/YHS'
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MQ7QR_P"??P[_ . 3?_%4 >V_\%PO]3\*/]Z__P#:-?E37NW[3G[9'CG]J]-
M7QE%IT8T7S?L_P!@@,>?,V[MV2<_=%>$T +[5]_?\$Q/VXG^#GBF'X;>,;TG
MP9J\VVRNIFXT^X;@#G_EFQX]B<U\ 4JL58$'!'((H _JCBE2>-)(V#QNH964
MY!!Z$&O@+_@IE^PG'\9?#\WQ)\$V2IXTTR(M?6D*_P#(1@4=<?\ /1?7N!7P
M[\-_^"J/QK^&O@G2O#-K/I>IVNFQ""&YU&V,DY0?=#-N&<#BND_X?%?''O;>
M'2/0V+?_ !5 'PU/#);3/#+&T<L;%71QAE(Z@BHZZKXH_$*Y^*GCK5?%-[I]
MCIMYJ4GG3P:=%Y<.\]6"YXR>:Y6@#]"_^"+_ /R7SQ)_V"&_]"%?L[7\V?[-
M_P"TWXM_9=\67GB'PC'8R7UU;FVD%]$9%VDYX (YKZ-_X?%?'+_GW\._^ 3?
M_%4 >G_\%M/^1P\ ?]>LW\Z_,>O;/VEOVMO&G[5.H:3>>,(]/CETV-HX?L$)
MC&#USDFO$Z "OT]_X(B_\C9\1O\ KRA_]#%?F%7MO[,_[7'C7]E34-8N_!T>
MGR2ZI$L4XOX3(, Y&,$8YH _H[K\'O\ @K/_ ,GI>(O^P=8?^B%KHO\ A\3\
M<L?\>_AW_P  F_\ BJ^6_C[\=/$/[1GQ)O/&_BA+5-7NH8H'6SC*1[8U"K@9
M/84 >=4444 ?L9_P17_Y(_XO_P"PF/\ T&OT;K^>']FW]N;XA_LM^'M1T;PA
M%I<EI?3>?+]NMS(V[&.,$5[#_P /BOCE_P ^_AW_ , 6_P#BJ /&/VZ+R>Q_
M;*^)5S;2O!<0ZQYD<L9PR,$0@@]B#7Z0_L(?\%*O#?Q,\-Z9X*^(^H0Z#XQL
MXUMX=0NI L&HJ.%.X_=DQ@$'KUK\A_BI\2=5^+WQ!USQCK@A&K:O/]HN!;KM
MCW8 X';I7**S(P=2593D,."#0!_5)'(LT:O&RNC#(93D$>M>#_'7]B'X1?M"
M32WOB?PS'#K,@PVK:<?(N2/=@,'\17XB_"/]MGXR?!6&.U\/>-;[^S$.?[/O
M&\^$_P#?7/ZU])>&O^"SOQ8T^(1ZOX>\/ZH%7 E2*2)R?4_-C]* /IV7_@B_
M\)&E<Q^)/$B(3E5:6,D#W.VNZ^&G_!*'X&?#_4$O;W3[_P 5S*0PCUB<-%D=
M/D4#^=?,$/\ P6UUD1()/A]:F3'S%;D@$^U8>O\ _!:SQY.LHT;P7HUJ2,1M
M=L\FT^X!&: /UZTC1['P_IMOI^F6<-A8VZ".*WMT"(BC@  5Y9^T)^U1\/OV
M:_#<VI>+-9A6^$9:VTF%PUU<-V"IUQGN>E?C?\2O^"HOQY^(EN;>'Q%#X8A8
M;7718!$6'<$MN-?+/B#Q-JWBS4I=0UG4;K5+V5BSSW<K2,2>3R30!Z;^U'^T
MGXA_:A^*%YXLUL^1;@>186"G*6L )*J/?G)-?MI_P3B_Y,K^&/\ UY2_^E$M
M?SV5]<?!W_@IK\6?@C\-=#\$>'X-$;2-(C:*W:ZM2\A5G+'<=W/+&@#]W?$G
M_(MZK_UZ2_\ H!K^8CX@?\CYXC_["5Q_Z-:OL:\_X+ ?&^^LY[:2W\/;)HVC
M;%DV<$8/\5?$NK:E+K&J7E_/M\^ZF>>3;P-S,6./Q- %6BBB@ HHHH _;;_@
MC3_R:OJ?_8Q7/_HJ*OO*OY[OV<_V_OB3^S'X#G\)^$H=)?3)KQ[YFOK8R/YC
M*JGG<.,**]3_ .'Q7QR'_+MX=_\  %O_ (J@#R[]M[PSJGC']N+X@:+HUC-J
M.J7NK+#!;0(6=V,:   5^GG[ /[ .F?LUZ'!XJ\40PZC\0KV(%G(#)IZL/\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MH8ODT;32J16P ^59&'"=N *^+[[_ (+7>.IM2,MKX'TFWL]W%NUP[MCTW8H
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MR:;XG\/ZAHE]'G=#>0,AX.#STK]:_P!E/_@K9X1\6:+8:#\5W/ASQ#$JPG6
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M-T6R\2?!/0=(U&,2Z??^'K>VN(R<!HWME5A^1->##_@FK^SF !_PBT)_[>J
M/P)HK]]_^':W[.7_ $*L/_@57FW[2'[ 7P'\#? GQMKVA^&X;?5M/TYY[:47
M.2KC&#B@#\9/"_\ R,VD?]?D/_H8K^AG]M7_ ),Q^*/_ &+4W_H K^>?PO\
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M"D5JI#*VQGR<]L*:Y[_@GI_R>A\*?^PHW_HF2@#]+O\ @LI_R:KIW_8Q6O\
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MI-F) I4'/T8UXG_P[7_9R_Z%6'_P*H _ BBOWW_X=K_LY_\ 0JP_^!5?$O\
MP5!_97^&'P!\"^$M0\!Z/%IMU>WDD-PR3!RRA01Q^- 'F7_!(S_D\W2/^P1?
M_P#HJOJ;_@N!_P D[^%W_85O/_1*5\L_\$C/^3S='_[!%_\ ^BJ_2/\ X*$?
ML@Z_^UUX9\':9H.JVFER:->3W$K78)#AT51C'NM 'X&5<T>\N]/U:RNK!F6^
MAG22 I]X2!@5Q[YQ7Z&?\.5_B'_T-^C_ /?MO\:]H_9L_P""/VG> ?&.G^)?
MB)XAB\0_895G@TBSA*1&13E6=B?F&><8H ^S-4FDUS]E2>;Q&,7%SX1\V]$W
M&)3:9;/ONK^;.OW._P""F'[5VA_!GX,:GX(TN_AD\8Z_!]DBM(2";6 _>D<#
MH"HP/K7X8T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MT_:3USXF7OQ2UG2_BGJ^H:GXDTVX>"47LA*K@X!0=-I'0@5]B?\ !)?]KAO
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M5_0AX5\0Z3XTT'3O$6C3PWMAJ%LLUO=QX.^-N0,_T]: /R)_X+:?\EO\ _\
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MOQ#^RM+I6GPFXO[[P;]FMXAU>1[+:J_B2*_$)?\ @G7\?6 _XH.['?[XH \
M_P"$KUO_ *#&H?\ @4_^--F\2:O<1-'+JM[+&PPR/<.0?J":^@?^'=7Q^_Z$
M.Z_[[6J&O_L#_'#PQHM[JVI>"KBUL+.)IIYF<811U- 'A_A?_D9M(_Z_(?\
MT,5_2!^T)\1-4^$G[.GC'QEHJ02:MHFC/>VRW2EHBZJ,;@",C\:_F_\ "_\
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M_P :KWNL7^I*JW=]<W2KR!-*S@?3)KZ'_P"'=7Q^_P"A#NO^^UKAOBU^RO\
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MD#^*1#U/^[7TO:_\%7/V<=6@5[_5=0MY1C]W<:/+)CCL0IK\*:* /VV\:?\
M!8/X*>&=/?\ X1JTU;Q',J_NX(K4VJD_5QP*_-+]K;]MOQO^UAK4:ZLRZ3X:
MM)"UGHMJQ\M?1W/\3X[U\[44 %%%% 'WG^P[_P %(/#_ .R;\(;KP=J?@S4M
M?N9M3EOQ=6EW'$@5T10N&!Y&P_G7RU^TQ\7+7X\?'3Q=X]LM.FTJUURZ6XCL
M[B0.\0$:)@L.#]W/XUYC10 5M^!]?C\)^-- UN6%KB+3=0M[UX5."XCD5RH/
M8G;BL2B@#])_VGO^"KWACX^_ GQ9X!LO .K:5=:U D,=Y<7L3I$5E1\E0N3]
MW'XU^;%%% %C3M0N-)U"VO;25H+JWD66*5#@JRG((_$5^H?@W_@LMHG_  K6
MP\/^.?AWJ'B+4_L0M-1N8+N)(;OY=K':RY&17Y:44 =#\0=3T'6?&NLWWA?3
MKC2- N+EI;.QNI!))!&3D(6'!Q6;H6O:CX9U>TU72;R;3]1M)!+!=6[E7C8'
M(((JA10!^FG[/'_!9'5O#NGVND?%30GUY8P(QK.GD),1C[TBGAC],5]16G_!
M5O\ 9PU:%9K_ %6_MYAQY<^CRR$?B%-?A310!^U'Q"_X+(?"7P[ILG_")Z3J
MWB6[&5BC:'[+&/0G<.GM7YJ_M1?MJ?$+]JC4T_X2*\6PT"!R]MHECE8$/9FY
MRS8[FO :* "OH+]B']IK3OV4/C)-XTU/1+K7[9],FL!:VDRQ.&=D(;+ C V'
M\Z^?:* /K_\ ;Z_;AT;]L:/P>ND^%[[PX="-R9#>7*2^;YOEXQM QC8?SKY
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M1&#*RG!4CH13** /U ^$O_!9"P\-_"W2/#GCCP)J'B75[6U^R75];W<:1W*
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ML;-[9*BOFOX]?\%G+S4]/N=,^%OAIM,D<&/^V-68.P!'WHXQT(_VJ_+SUHH
MW?&WCK7_ (C>)+S7_$NJW.LZO=OOFNKI]S,?Z#V'%=?^S7\6K7X%?'3P?X]O
M=/FU6UT.[-S)9P2!'E!C9<!CP/O9_"O,Z* /UY_X??>#O^B8:Y_X,8?_ (FC
M_A]]X._Z)AKG_@QA_P#B:_(:B@#]>?\ A]]X._Z)AKG_ (,8?_B:^<_VXO\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
6%%% !1110 4444 %%%% !1110!__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>img236010591_0.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 img236010591_0.jpg
M_]C_X  02D9)1@ ! @   0 !  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  _ 94# 2(  A$! Q$!_\0
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M8\-:;X2T*#2=+BV01#+,?O2-W9CW)KA_B]\,8_&6F'5-,B5=<M4^7''VE!_
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@% !1110 4444 %%%% !1110 4444 %%%% !1110!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>6
<FILENAME>ofix-20231127.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Schema Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-12-01T14:22:04.9851+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema targetNamespace="http://www.orthofix.com/20231127" attributeFormDefault="unqualified" elementFormDefault="qualified" xmlns:enum2="http://xbrl.org/2020/extensible-enumerations-2.0" xmlns:ofix="http://www.orthofix.com/20231127" xmlns:xsd="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xlink="http://www.w3.org/1999/xlink">
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase"/>
  <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt"/>
  <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" namespace="http://xbrl.sec.gov/dei/2023"/>
  <xsd:import schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" namespace="http://fasb.org/us-gaap/2023"/>
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ofix-20231127_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Labels link" xlink:type="simple"/>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="ofix-20231127_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation link" xlink:type="simple"/>
      <link:roleType roleURI="http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document And Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>ofix-20231127_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-12-01T14:22:04.9820+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:title="labelLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation, State or Country Code</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Pre-commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Title of 12(b) Security</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl"/>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>ofix-20231127_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="US-ASCII"?>
<!-- DFIN New ActiveDisclosure (SM) XBRL Linkbase Document - http://www.dfinsolutions.com/ -->
<!-- Creation Date :2023-12-01T14:22:04.9878+00:00 -->
<!-- Copyright (c) 2023 Donnelly Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
  <link:roleRef roleURI="http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="ofix-20231127.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple"/>
  <link:presentationLink xlink:role="http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:title="presentationLink" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType" xlink:label="dei_DocumentType"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol"/>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="10010.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="10130.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="10020.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="10000.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="10090.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="10100.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="10120.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="10110.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="10040.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="10050.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="10060.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="10070.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="10030.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="10080.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="10140.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="10190.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="10180.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="10210.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="10340.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="10170.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="10220.0" priority="2" use="optional"/>
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="10160.0" priority="2" use="optional"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139806227596928">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document And Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 27, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov. 27,  2023<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">ORTHOFIX MEDICAL INC.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000884624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-19961<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">98-1340767<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">3451 Plano Parkway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Lewisville<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">75056<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(214)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">937-2000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common stock, $0.10 par value per share<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">OFIX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>ofix-20231127_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="ofix-20231127.xsd" xlink:type="simple"/>
    <context id="C_a7326e62-6655-42b6-88c1-3e2f178a2305">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000884624</identifier>
        </entity>
        <period>
            <startDate>2023-11-27</startDate>
            <endDate>2023-11-27</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_5bdb31d8-d687-4107-bee0-4af134e33bbf">0000884624</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_b22f4a5a-6020-436c-a772-eb2c606508d3">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_573a6153-94a6-40c1-bee0-42b0dd8deff5">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_500bf5ea-88da-40f3-81eb-4d3bff8e95d6">2023-11-27</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_9da5257b-ac78-4a77-b97d-4f3ef7b3e010">ORTHOFIX MEDICAL INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_87c32789-6ed9-48a7-90f4-7233b53b0b9f">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_2389cfed-281f-4912-94bf-5e17e5e8c31c">0-19961</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_7a439cfc-b80d-4f08-8aba-b93220c210f4">98-1340767</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_dd627814-695b-4bd9-968c-695a3a976ce1">3451 Plano Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_10988c90-7d02-4610-988a-4b9bb66b8416">Lewisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_516957a8-04d1-4e0f-8c09-168756761edc">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_f41a4019-de4e-456b-8aa3-a5d4581a58b2">75056</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_313b9ace-90c8-4934-8419-b5d1c7b1617d">(214)</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_81ae6a4a-b586-44ce-8bbe-d97034d20c96">937-2000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_5bd89842-4aa4-4eb4-ac74-8adde6fa0a8a">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_7f9624c9-d0e5-4b67-88b9-127e832c11ba">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_b805c53a-d286-4868-a855-732635845c3e">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_d408c16d-66d5-4a35-8e29-a0595f681b1a">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_01a8bd1d-a426-477d-8cf7-6b77e14ab9a4">Common stock, $0.10 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_f11c382a-2945-4818-a89a-35132dd0ff3d">OFIX</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_56e99c76-a3b3-464a-86f5-dc7a5a1981bd">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="C_a7326e62-6655-42b6-88c1-3e2f178a2305"
      id="F_96079a35-816b-49ae-b6c6-7bfc34e5c435">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
M[H.!5Q'YTAA;!   EQ   !@   !X;"]W;W)K<VAE971S+W-H965T,2YX;6RE
MF&MSXC84AO^*QNUT=F>2^(*YI< ,(4F7V5QHH-V==OI!V (TL2U7DKG\^QX9
ML&EJCIEI/@3;Z+Q^?'3\'HG>1LAWM6),DVT<):IOK;1.;VU;!2L64W4C4I;
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MX%<KF+J^52D-6-^"PE5,KIDU^.D'M^7\C/ U"KX&IEXF<+9+614<'MZY_HI
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M-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%     @
M[H.!5P=!36*!    L0   !               ( !     &1O8U!R;W!S+V%P
M<"YX;6Q02P$"% ,4    " #N@X%7>7EOJ>T    K @  $0
M@ &O    9&]C4')O<',O8V]R92YX;6Q02P$"% ,4    " #N@X%7F5R<(Q &
M  "<)P  $P              @ '+ 0  >&PO=&AE;64O=&AE;64Q+GAM;%!+
M 0(4 Q0    ( .Z#@5<1^=(86P0  )<0   8              " @0P(  !X
M;"]W;W)K<VAE971S+W-H965T,2YX;6Q02P$"% ,4    " #N@X%7GZ ;\+$"
M  #B#   #0              @ &=#   >&PO<W1Y;&5S+GAM;%!+ 0(4 Q0
M   ( .Z#@5>7BKL<P    !,"   +              "  7D/  !?<F5L<R\N
M<F5L<U!+ 0(4 Q0    ( .Z#@5<ZJJ+G0 $  #P"   /              "
M 6(0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    " #N@X%7)!Z;HJT   #X
M 0  &@              @ '/$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL+G)E
M;'-02P$"% ,4    " #N@X%799!YDAD!  #/ P  $P              @ &T
L$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"  #^$P     !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ofix-20231127.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document And Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document And Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="ofix-20231127.htm">ofix-20231127.htm</File>
    <File>ofix-20231127.xsd</File>
    <File>ofix-20231127_lab.xml</File>
    <File>ofix-20231127_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>16
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "ofix-20231127.htm": {
   "nsprefix": "ofix",
   "nsuri": "http://www.orthofix.com/20231127",
   "dts": {
    "inline": {
     "local": [
      "ofix-20231127.htm"
     ]
    },
    "schema": {
     "local": [
      "ofix-20231127.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd",
      "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd",
      "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd",
      "https://xbrl.sec.gov/country/2023/country-2023.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "ofix-20231127_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "ofix-20231127_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document And Entity Information",
     "shortName": "Document And Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "C_a7326e62-6655-42b6-88c1-3e2f178a2305",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ofix-20231127.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "C_a7326e62-6655-42b6-88c1-3e2f178a2305",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "ofix-20231127.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.orthofix.com/20231127/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>17
<FILENAME>0000950170-23-067364-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000950170-23-067364-xbrl.zip
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M_ A&SG.>96/R4>0LCP7+R'DS9 OF&+?)7I:1,_RJ(F>\XN453]K8Y9_>]6O
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M#IN(J^:C1%3#C(V1]!S>OA,W7>R;E^J?(DEX+O\YY0TBDO=;'__E1DEDFTE
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M%JD)V37J 4!?*]TY*O01.UE"KEB)/$T*:9\S>4=CU1=#J:V!JO5T\C*= 6B
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M@/LZ";$#5O/N=$.MJ1: 7A-=[YN ?]>)BF3\X4_O.OUZD'WX?U!+ P04
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MM%$*AJA0SC$+ZIQ+E26JKD$3.45]2W)4!4FQZ[4J$5+/Q(0NJR(L:QQWOGA
MM)9T7&J\%C+OX8243'>]DO\N":,3BIG97X9V8S8 +;=I"%<)\C+OK F78\D,
MX]0212$N-7)%QPQ]"T-9;9OR.[9[=;A5]AJY-=J4O %>'#5D41P^W SJCCHP
MH_S7!KHE+CH*K7M,%#IXJ?PI(<4Z8D+4N$(WCDJ, V=(-VM6F 93,0^-8P-H
MG9G>MC_125@[VU"Z1[ 92&V&9"UX^:+ 9COBT]/3L/)ZYQ\ JD&A>6%V%NIY
M&8BTZL0>,OOD.T;?FNR('\6!2>8!WSII.^2&_R;"]>E=(M9-?J\(UR3+?K*+
M=VM77\6H=LV/7?AVL9?SQ=2]C73KB(?(M'*6O1*VGY G"81SH2M>:W+&HJ!\
M(FJ+L=D.):Y-0YQ -;@)D:D4#/>/=UA(4:#4%%7[.%<)9A(G7<_>)+Z[11X9
M&0?F[#C("X+-V;'NT(0@&SS)<[&::AL\L&X%U5ESGE5A',KL/VO&[K_764A\
M:YTF1)F[ONK6[G)_ME"O+MKFOS-^L(O[8?_OUWVHR5)PD:]J;>X-[?XO>?:=
M&T6KOADDF5=J/*#FU3 T\,=7P9U$)S)#\\*GU:S&D?V9SX'6E\%Z:9)!G0U:
MZ<["YTF>I2\59C_X>;5^OM5-< /9$Y@2EI;L[7%/LG:&-4;7JN:\AL\.;&-H
M'>O:4E\RYW\ 4$L#!!0    ( .Z#@5?>_]+?E@4  /TQ   5    ;V9I>"TR
M,#(S,3$R-U]L86(N>&ULS9M=;^(X%(;O^RO.LC>M=D* SL46M1VQM%VAZ9<*
MHQWM:C4*B0%K@HV<4.#?K^W$*4F<P$*=]*HA.7[]',=V?([=RR_KN0^OB 68
MDJM&N]EJ "(N]3"97C6^#:W>L#\8-+Y<GUS^8EEP<S=XA$>T@IX;XE=T@P/7
MI\&2(3@=/IS!]S]>[N$>DY]C)T!P0]WE')$0+)B%X:)KVZO5JNE-, FHOPQY
MA4'3I7,;+"N6[S/DB/MPXX0(NIU6Y]QJ=ZQ6>]3^W.UTNJW/S8O?.ZW?6JUN
MJ[55C"XV#$]G(9RZ9R!*\;H)0;Z_@3M,'.)BQX>AJO03#(C;A)[OPXLH%< +
M"A![15XSTO2Y!UU?N;$.<#=P9VCNW%-7XETUMOQ9CYG?I&QJ=UJM<SLI56@A
M?EG*S!*WA(OG[>8Z\!K WP8)9-U[5*+,USG[U;FT;E]<7-CR:6(:8)TAEVW;
MWQ_NA])/B[^AD+<::ER? ,3-X8R1+UXM2+TNHSXJ012/[;AB:1_B4!1(9)+[
MFP6_C=8A(A[R9(5)E=1-&?FB^2E3)6<,32*"@"/(Z@/D-J?TU?80MD4W$!>6
MN!"-^RO_\:-/>5_OC8.0.6ZHE"3452/_W#:-T^/CPQ-CY,YWIAJ<]'/C.'T<
M;GI\#/:IAW2-L_W8.(R:/IX1P]2[)9Z8%#14>KO*\$9<L81*/C8.<TM"\6X\
MCZ$@B/_P48;:&K)BVVHQ16]Z8B.Z(KL@MRRK17RF?![T_\:+@@%18EPMZ##D
M??Z)/3/ZBL6\O0,U:UX1;)^/!^;X S[3K[^B32%EUJXBO-LY8E.^[OF3T54X
MZ]/YPB'%D'KKBE#OL(\>E_,Q8H5\6R850?%5%64+RN0:27:Q/EWR-[DI'3WE
MI2I"?T%3++[Y)'QTYL6L&;.*X$;.>N#Q(8$G.%I_[GCS1?;&<<7ZV'^>45+<
M-W,FQJ&>&>]0<_XI=I'X'@^"8(G82*PVV=-DHH7<6:1JZ/^%6RGH$+E+QOM<
MNS,>B16^!B]G4AG4[=J=.62*"L:TULP\'/6QBT/^Y7C@<QWCD:D.+6]D'&S$
M'!'U#S?S,=4QI9\;Q_F+OQH>%(J>O23Q1!9HL/1V:3QA+0)@?B72&HA8WX;I
M )2OBNB2:5=.J9#PAS].VF:O$%CH-*ZE!ORC5/Z]M-]J>3_25+1X(&FB 4+$
M#.=V''EH@W()$!H@1,Q@:@/+ WF37%@D!EQ-)KG,DHO@\UA@H6&&LC 0/1 Y
MTH-8Z9.Z$ E)!$^D"B_>(M5W\D'V<\I 2%; GXIAW\F%2!.XJ,&Q6A;>OI,?
M4E6\"Z5KTI-,"'R<"[$82#7@<B;)M7'Q<?Q*$B)-B$5->O$6/1^'+G0@$C*)
M6QI$'^=!2GIK%,05&!_3Z9C[.%_>M$"(F<0N",*/X^>BD%8UVK>RP?J!\%(&
MI(Y1W%UA^X'X7-9RMW0A$H9(&:1T)0X9<,6\#]GH_T!R61;H!-J=T_$9*%6S
MS-N)@0.YE10H+8,33SYI<"AT(@1*R0QQ*J5P:,^(-" 2,<.IS3$<R!MK05JL
ME+O'TND5A[FJ8GZYH^[8PG8I'_2+T(HPXN(31N>ZC6]5'2U*@>3S*U5 :K?+
M%60^^U$/I&X3/6G(;.:C'L32K77%6IS^J!=Z>\,]RYHD/.I!W+D-KWC+4Q\?
M #Z_.:]%S^0[/@"X=LM>RY[/=7P _(*-?*T#NC1'G2X4;.^GV76)C3JA2S?]
MT^C%F8TZ'<@?!4A39S(9=:+N=4 @3;\[L5&G0_IC VD/-/F+.I%W'"9(LY<E
M,>IQHNB(@>+6IBSJ0=WWX(%"WRM]\2%<V=^)CX%?=$A!06MS%/6BZHXN9'%S
MZ8F:D L/-"3 ^L1$/;C:8PZ*-)^0J >R]/"#@BW.2DCH[90"CRU^7I^H.SCZ
M]X'K_P!02P,$%     @ [H.!5P;[NLV#!   ["0  !4   !O9FEX+3(P,C,Q
M,3(W7W!R92YX;6S=6EV/VC@4?9]?X<V^M-H-^6"Z,Z!A*I:9J5#G P'55OM2
MA<2 5<>.; /AW^]U((1  NT#T:8O!.)C^YSK>VW?*^X^QB%%2RPDX:QC. W;
M0)CY/"!LUC&^C,SNJ-?O&Q_OK^Y^,TWT\-1_1:]XA;J^(DO\0*1/N5P(C-Z-
M7MZCKW\/G]$S8=\GGL3H@?N+$#.%3#17*FI;UFJU:@13PB2G"P43RH;/0PN9
MYG;XGL">?H\>/(51V[7=INFXINV,G>NVZ[;MZT;K]N;V#]MNV_9>-QZM!9G-
M%7KGOT>Z%\S-&*9TC9X(\YA//(I&Z:1_HC[S&ZA+*1KJ7A(-L<1BB8/&9DP*
M"MHTE1%+TI;^'(?>,_<3>AUC3T\\$;3!Q<QR;;MI[7J5(O0O,X69^I66V'0:
ML0P,!*O!9#+W#TR2PN,C_*J9H)U6JV4EK3NH)$5 &-:QOKX\CQ*=)JR0 JMA
MX_X*H8TY!*=XB*=(/[\,^[E!N%!S/B5QLIK:_([CWEC*BSGCX=K27:S4&=)G
MEP6/3!&U[K,I%V%B5R"9S#47>-HQ](AF.IJVSN]#&.C;SPRDUA'N&)*$$<6&
ME8F)!"PX4PE6N^L6KHE>5!B\UC,<3I^GBV.%68"#Q/@I8\K]'(AJ5^0B;S'-
M7 +UQ%LD]ALSOK0"3!+J^DMBSL24\.-;CT/<=R=2"<]7Z4C4FV#:,8[;K4O3
MZ8+U FW!)^K-"NCDVR].IP=+V(7]J,<#7&2<_>:+DTF=:X %X>!?@=X@"U@5
MXRJC-X813[!*FB].9A-]W2" *)/;!T09=@J8E6.KI:F]Z4V,^8J=([F'K);B
M@,.90/\E44E G !72W0$&RM^$P/!ET2?86>H'L(K(MN#>! >[<-.'W_&ZU*6
MA[B*Z#V&6,S@#OA)\)6:]W@8>:R<9#&Z(JI/A.+713C!HI3?'J0B4G##Y"+B
M(CGC$Q?K\06LY/ID])SN51'U(9X1?>8S]>J%Y5P/8!61&WMQ/X"0(%.RN8N?
M6?DR_,7IZER!#N:<E?OF$>3BI 8"'"J$H]C'^CSN2[G 8JQOF^)M.BTD>;9+
MU:1_BFZE1$?87PCP.<>=C/5%OX#>$:0R4H^Q/_?8#)?$="'L\N0X)3Y1<'*\
MP%XG($LOHG8,NCBQL?!T!62T#B>\B%.^_>)T_H&E@:10>_:";3<R64"K&)>C
MMY][=D6>JB?\=%#X>I0-YXL06X05>0+&,_TYH4':>RIX6)1#IK/QHHP.<0&Q
MVC$<VW9L78>*((?1/MDQ7 ,M))#AD:9]Z #_)TGYK'&GR&G65E%)ZIDMEEM[
M:9NT-5-DUU;1B=PWD]?Z->3MY\Q9H/TB:W>0;6?ZZAMMIY/T3&%]-_^2S#Z+
MO.N:2RNI"F0"/]1<X'XM(5/U5\U5G2E&9$)O:B[TL'21*:OO_>M,W2.3>%M;
MB<>UDNPTJ.^6>;[8DJFL[Y7L5'4FTU=?WSPNZNQ4N?6]J117A7;*FO6-NJ*2
M4N:']3W@#BI2F1/6-R$HJ6IEJ_5C]ZX[ZT@9I+S?[Z^V#?I#_UOF_C]02P,$
M%     @ [H.!5R<:9J2 $P  EX8   \   !O9FEX+65X,3!?,2YH=&WM76US
M&[D-_GS]%6SNI?;,2K;\DN3L-#.*[7;<)G8F=GKM3&<ZU"XE,=Y=[I%<R>JO
M+P"2^R++B1LGD9/L?;A8*RX)D 3P  2H9U.;I<__P)Y-!4_@7_;,2IN*YR?_
M[ VV^X-G6^XC--CR+9Z-5+)@QBY2\>='&=<3F1\P7EKU1YD52EN>V\.")XG,
M)P?L:7%]^(BZ+<(K8Y7;GI'_%0>#[<(>NAYZ5A4'VX?TW9AG,ET<7,I,&'8F
MYNR-RG@>&HZ4M2J#ME9<VQY/Y20_T'(RM3#.,WP_C!.K5.F#'[?IO\/Y5%K1
M,P6/Q4&A16^N>7'8(&4'2'GOZ##T7"9V>C"6MA=#2Y'CD"?74SF2EKG)PAZ>
M/]LJ/CO',8PN-+(LLPDS.O[S(_AC[]>=QX^?#)[^9[O_KI@\8CRU*Y][NAP_
MCW?V8)&F N?PX.D^+=@O/PX>;Q]^64:::_>Y5BOP]<76Z5UIK!POUK,WS]1,
M9".AV<Z3B.UL[^RNG_%O?6&_&?Y2,5Z31GW%C9&98D<\Y6.IM/@NN/Z'Y.QE
M'Y@V5J0S8;5B@Z??!>>O5")R'K%3R],%VQL,=O;68DB_23%>J_TY%EPS+\X'
MZV>Z6]1/P>VI91,Y@Z:98!,MN&5%*K@IM6!6,1C)0#MFI](P-1X#^%!C)K(B
M58L,OYA+.V7GVD[56%ZS5R*1,4]!^/.XSS;H2VD-,^7(R$1R+6$@GB>,C\<R
ME=P*$[%??KS>V1[$AZ$7]SDYW.RO?PVZ/>8&G#MW8J32Q/6:B%AI;J7*#\H\
M$3J5N?A_)L8U12(.)!@*&=\Z5:^5D31.F*TO+R.,74X%*SPA;"X8!_$@<0"O
MF"U4R4 \[!2$!Z3C-<B,3% X<*<?3:48LY-K$9<6Y(R=P\Z/A>ZSWZ"7U"@F
MK@L16_>VA6$J87JAN$ZPPV.IH872!J0M31DO"B6A=QR6@U3F2 J)64;N@>FO
M<Z;6OZ<[F5V[S%Y8KBT[!OV^5JG]ERHU"*&5L2R E@3&![I09!/XB#+KA ^^
M 5LW$DR 2,<DIIE,>O@PA8:]O_&\Y'J!/O=>!#91984%;#M6::KFV!W*;0Q/
M4T$* L3QI<SXD=(%3KAP%NW70X/V="95:>!MGN>JS&,8F\>_E]+KEM&"G>1J
M!J2%M_'IQMF_+DX.V,G9^3\ZJ]A)&-#[@AO!+L"EUHOUB]@(B3%$C#-1($H_
M/=W9CV!L5@!F7*#GL(%2$L!>@_X*[T4L%<:@?0/.^2@5+!%)&>-T.M1H^34!
MSBE,.(B=Z42A$X5'SX<Y:.<4X%)>FK7*PD4Y>D=03M4@KE! >O!Z#,R'&?,X
M&(G&3@<I&2L-_<=@2310J"6/".(%@1*P3!*;HEN&9LP9-29S,C_<S<((9P%-
MU$3S+'+N&0?!T1-A_9>JP&.=,I=V@40,!ML_X[\+E.2&6/:]<*/1:_=.%.7*
M(E4P4D^3;44E ' U=QV1I24SVW?HN=E#Q.08>%@@YU'%8,$EV$('@@T'=]1*
M_!_B8E/&4_<JSJ3V;6$B%#368,4]NH:><9Y#CPD \4GNK+N0U!0G\AK\5\O&
M8,:9TLYN+]Q,G6+P* <RWXB9R$L!1CB!^1!NQ?:V?QU&"+D3 <U@'R#7"Z+W
M"#H1N7'6&DFXY"EZ ,?03ZH*<I6A32:M%037V\XN0H,5<+^E,8]^X5EQ>'E<
M]U,I3E86,*R .1^ETDQI-,%ARE#O=DJR4Y* R('\WGG.3@!J@MP/Y[C9-G[:
MC?:WM]%,;ZY5<PY1/X(F VLO:/>"P*(4R1SCN8C'03D"3HY%81W>!H <_/&V
MF@39$?@"9Z !<QLU,#TZR^-E]13ALPVYV=3 /:?+P(^W6L;.<5#Q%4.="5(9
M)/)U[\W%6]. +S.>EH)TV$^#Z,D^32S;J!0C>0DI4 T<%-!Q2Q&@'LJ@D1O)
MMR86/)FFMBX:'(>$YD%1LQS$'&AE<P!&@J@$8C8D,'5!O9T7#D.AY2AU/"6X
M-L5W;J6@Q<S3)_LK6'F1\OBJ=Q'CH,8U_SP,*2+?4;SI-#PP!]Q]:(%:R^,T
M/+Q2^$'O/P-?:C'[; B;FXP@1\$UU6YO](/R)',DN!&>M5/H?C)M(@VPDI4+
M#'/5Z('GBV9#%+=4> ^44C+,U^!\;G\MQN3>1W2/ESC]TQ%T/-+R3Y'AN>D9
MP)#CVY7NJ^'1F_,7;R\OS\_8L8I/C]F__[TW>#SH#;:?[O;VMW<&C,UV[FT5
M[D?DIS=*'S>^WPY3'8@H^ 3,A!;\JL?'@ 8/>#KG"_,%DJ-6;9O/.@E?&\JZ
M'QAQ1KW6DC74]ZZ)R FEXY^[/0IL-'TW^%NJAC-4602K * YFX/A"W!%M+"E
M!LTJ4D[PA#0P@2"P:@OH"=I,0'T7^$Q<@Z,TE6 ! F497Z % *4]!\=&.'\&
M7#GH9F?;N71(HW?]B"W&,S VEK6,&/@)$KP4,A?^G29#$\53 S[<Z9@EI0[!
M3IR4T'H)8V"7,S ;DQ7V,;A*0'3M^+1M);P*V$WEH@</P6#'Z$@E;I9Q9@&\
M -L"W)W?T9]$'U"[@TMX$9S%G WV:^X_AH)E:]UVPP*0=OSBP8Z.I<%.P8KC
MHP8>O#D[9+=Q!9W+A@U2HMR#4'Q 8^(Q$RTW]?&A,3&4[=<Q"?AH56<(E#,A
MW$9NF'I0 #-9X=XX=&N"[_[AEA4BR82]@;0&6[NK-XN? EQMDB2>YR )VF @
M<=4+8<F:J^,<_N4!!SNK1W0^0$..R4_>]9O-[['F1I\K\J)-(]I/0.Q]--?4
MP022.JG77>8A%+*[VX.)^1F>@#>2IBB QD=LL).QU-#<0E?QM$9M=YBQ&O7>
MG"B*K0A<-O]1@AOHQS#+@R#OKI46@BT-)X6YR6X4%@$:I1A!>EM0/&3!QJ7%
ME((C$- )Q:Q@[UJM4K9!\90Q:5CR@9V(WFB'A%P(5"RHE88@\:2RR-'97*VU
MR&G$;[Q.K\-"\&K2$!CKV1!!% =!@3KE2;ZGQ35K*LN K5?3&S1/-?652'Y8
MFF\AM$_"B"&MGB+]AY[\[0Y!T-,N]M@0U7;DD3I@/$SH6D^/UP\RNE#5VD-5
M/IY/<6<?KCJMXD A<+6'[OC: U<8MP+5IBFT?/_PU4?'KIR":T4L=L($?0L!
MJ,$MS*PY!+49C/O'!Y9NXZP++77*O_.@.P_Z&_2@R;!W[G/G/M_%??Z>O><'
MX3Q_']Y@=Q;3G<5T9S$/%$D^D+C=^W'+>X-VI@[;\49TPX?PZC#!IP_FL;_X
M&"B?*9F0>H<W$E6.;'07K@ 925R.!%DR'E=28E[38C0X".EWF!^8BU@8M':I
M\_X6R(DW9@XJ>H8W9%_T(S(Y0,\^]>+;$7KP8/"V"7#HK%Z &]EY-U+G.F?S
MP:B(=2;1BQS DUUOUG#EW]+^=366SM'PM9182H;_XKZ?24-2F9N2L%PS1%C#
M7H\L'2@GD^@BA^[;W6U0;@O3+N1TV;Z^P S+TCZ<<5P1OK<]V+C";"PKM5.Q
M10I>9.TKW(>J2XJ58G]QJ34\ RU2:#63"255^\;05\8M^A7>"(2C']?YSL\4
MP])R5%89NON-5CGL.[;7;@1C#X%830J%RQ2C7]=(" _IVY84^\AO(NI4^21C
M_ZA*;78$4R(RKJW#ZD; K.*$QNBS]QM; 3 ]N E![]/;)B@[[-<SW1@<"3,A
MP$$?,%("HT^P[SQT!7SZ* 7Z%<#N&.3#%2HV7_61D9BL([H6DMQLZ&^!.C70
MV6G13HL^>OY&I"IV0C$T1H([#HII_45)=;FN%T(7<Y'YBMS[(ZY3,^))Q(Z&
MJ()E'.K4#84KHB4M[>79G]Q0B86N9Z'@I+PB7U08:A6P,7S["F1K$/E:0HIG
MA* B!4:J.F",)F1464&ZLH?%3UBX0?6 8!CB,N6^<I$;4X92":H*UBWL^+9_
MT6=CD:  NYID6$]0?;GD>)A$&CU6V &_CAAH/P)OC0[JKQW!"Z_GWI5:&K!2
M2-,F*A5WCN"XJ>I60I3QIQU7$1:Y9GZ6_"25N#:DC[$D,\<Z#SQ)*:E6I2YM
M0&3NRZOC13!$%S"%QU),%"T?,(\H%<'_2(Q1?P_+"0@7&^R[67\ 6NO[*<;^
M"O37)8;Q>J\!X"S0\1E3[;Z$5^QBZTSE/:KM 2$YAQTX(8H>"&#4,$63''IS
M=P^0]4^]4L+S#(\2?'R7L%:A)8J8QTS&G3VCM9_RF?"G M>@.9U>B1NS077/
M\#I@(;T@,+J%X$GSA&*B /Y ',DA=!HJ1/MOFUUV6K>N;_Q@[!5(+$*6Z%8^
MB6:BE[-43*"KI,1$&%!L%2?<03GO_=/WJ-. )U TJ!H2:=#3%^PN]#%56M0Y
MU1'\\@4H#L="<]&87&"FYH$P]2I&D&0U%ZN[> \?A@H++8N%!G2*Z!@\Z@S?
MJ<L?ZO*(H_!M<ZHKXO!$*%?.T0_@5HVP6]2WJ._O-$O>-N #/.[*&98Z1BO,
MK:NZYR' 4,V%\SY&.-,CM\="==ZX3'V-7C,2X&%L'>YH;^<;Y_)H=AJ;%(A\
ML:# #+(Y @,^=P*A1;CWAH QUQ2B;^\](DR*I%%QZ&@-19= F#OIJ-4&VOLX
M+?%(OK:SJ<RDL^/0%?724D$1-,I[?K6Y2QC!)S%I)9]!@B2 U-I>8V/Z'8XQ
ME 8)WL\+.2MWX12)S*3AA5, #I+<=4] M]&2\]%:(\P$,&;5ZC3R8I""2F!!
M>%&&8>M34@T04I0:5987%;UHQ\ONN4DB') P"GE:M=#XW3[GBP< *#HWZ%-P
MV];6<\";#H:*W-V'U<37N"?!68Z=2\$;[@;YT1G"&=A7OY=2.Y/<T-FK%#.5
M(G/<V73NW!!>M]]A&]]%X*)0Z%PI<W+:%3[@"=A52R$4EXX0>,&30?A^IM*9
M9P<V]CLU MT(=J?!5:S*-/DXKGSC9?-[5T7BM $),7DD&8;'0!6E9!!AQZSR
MZNCJI9<$$?RU2]UI9G>:V9UF=J>9Z]  %$]*9GB^=B==57D;T 5\).QVZB(>
M>#N%10@D6Y=1D('B3$MS19'B#!$;!II;Z+&V+5$P+HD2B,JEL<N1+LNO*($I
M0#^6N<LAN[MW'LZV7&/LY*3R-WI#V_L-=LQ]]&J3D<]"[KJCTN[@!R/D+H.,
MQU>YFJ<BF0@?PI$.E8T$15RK"$[CT*5]W07/J[Q*#A,(3X.'7Q\2H5) 429*
M?7+>4ABC'^[@\)U4+X.?JIHWO"+5U?CD0*$^HA1N<KM(%:&>6(Z3(!& ]9 (
M[R&#[L%_%?C!!!&#)]W^"M%=C'5TPQ9EKD^$Z:"0\CJ&H FW)J65>!D0_=A%
M1(YYN)W'C1+.S>@ZG[G L(-+O(U=9BMF-QB5YR)MW^#DXMZ@#0'WHQ:,EH_*
MT%D,<U#?9H3I]JAV=74_8#VA];P DZ_Q[EUR+D0KIM>X?S<5%H].39F!1J%8
MTF+YFL/;\B1NN[>78BH+8L7QX2;)V9<'+= P46L4Z>KXF:8T1.JZZU<[J[Q>
MJWQ.6JI*\UWO<<7;%;D.*VO>[IRV#-J)'4M3E-#=&P'*U25UM+Y?.LBAKD[S
MF8]OXSGU)">I;;Y%5AF:)2++)6!PWNZW7<:P/,F-PH56/IHSY*L*^5QN2L(7
MRTDOP\0I;0S= "#_R^D_7>3#%="%ZV>UD-FHU#ZV@L'0#;Y)A[28Q($Q[2W\
MX(MD8%%I!9"CZHA5YI140_@B=$*DT8\W1.SMA9L5.B7>P@/NE-5]NAQQJ@"H
M:DPHS]UCC+IH@NLVEFG4D+@<R]&FM[XN3\@=ZXR1X[)P9\?N_B4L:A,S"=O.
M)=\TP4 CZ9$-H6//93U/+OI+H3!V)1LHH,J=7S:RA"I@,X,BL+C;*"]'BZ2%
M*,B6^J-H!"-4 S!NW1H8<I]6WR_H$G6P^ ,/TY2NTX4P%!>#UG")FU5Q@P_
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M.T^H3FSWJUBI3^?M?IT_T-[I[H>INY]MC52R>/Z'9UM3FZ7/_P=02P,$%
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MA[GM3Q%^G?;E#&(TE&8I5_XO:-R^=29LB-L0MR'N1HWJ*"1,I@H;8O@)+\<
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MOAL  &]F:7@M,C R,S$Q,C<N>'-D4$L! A0#%     @ [H.!5][_TM^6!0
M_3$  !4              ( !^1X  &]F:7@M,C R,S$Q,C=?;&%B+GAM;%!+
M 0(4 Q0    ( .Z#@5<&^[K-@P0  .PD   5              "  <(D  !O
M9FEX+3(P,C,Q,3(W7W!R92YX;6Q02P$"% ,4    " #N@X%7)QIFI( 3  "7
MA@  #P              @ %X*0  ;V9I>"UE>#$P7S$N:'1M4$L! A0#%
M  @ [H.!5YVM'4VK$   Z6<   \              ( !)3T  &]F:7@M97@Y
=.5\Q+FAT;5!+!08     !@ & 'X!  #]30     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
